Published in MBio on February 25, 2014
Primary Prevention of Infection by COVID-19 in Health Providers (PI-Covid-19) | NCT04420260
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis (2014) 3.25
MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis (2014) 2.47
Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis (2014) 2.13
Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis (2014) 1.96
Middle East respiratory syndrome coronavirus: epidemiology and disease control measures. Infect Drug Resist (2014) 1.91
Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis (2014) 1.89
Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill (2014) 1.69
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother (2014) 1.66
Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev (2015) 1.64
Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission. Epidemics (2014) 1.60
Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg Infect Dis (2014) 1.59
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci U S A (2014) 1.54
Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J Virol (2014) 1.52
Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4. J Virol (2014) 1.31
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A (2014) 1.20
MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013-2014. Emerg Infect Dis (2015) 1.07
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design. Vaccine (2014) 1.07
Acute middle East respiratory syndrome coronavirus infection in livestock Dromedaries, Dubai, 2014. Emerg Infect Dis (2015) 1.03
Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. J Virol (2015) 1.01
Lack of middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis (2015) 1.01
MERS coronavirus: diagnostics, epidemiology and transmission. Virol J (2015) 1.01
Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases. Transl Res (2014) 0.98
Animal models of Middle East respiratory syndrome coronavirus infection. Antiviral Res (2015) 0.98
Bat origin of human coronaviruses. Virol J (2015) 0.97
Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia. Emerg Infect Dis (2016) 0.96
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. Emerg Infect Dis (2016) 0.94
Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in Alpacas. Emerg Infect Dis (2016) 0.94
Coronavirus infection, ER stress, apoptosis and innate immunity. Front Microbiol (2014) 0.93
High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014. Infect Ecol Epidemiol (2015) 0.92
Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. MBio (2014) 0.92
Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J (2014) 0.92
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res (2014) 0.92
Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis). Sci Rep (2016) 0.91
Concerns about misinterpretation of recent scientific data implicating dromedary camels in epidemiology of Middle East respiratory syndrome (MERS). MBio (2014) 0.89
Time Course of MERS-CoV Infection and Immunity in Dromedary Camels. Emerg Infect Dis (2016) 0.87
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir. Virol J (2016) 0.86
Livestock Susceptibility to Infection with Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis (2017) 0.84
A phylogenetically distinct Middle East respiratory syndrome coronavirus detected in a dromedary calf from a closed dairy herd in Dubai with rising seroprevalence with age. Emerg Microbes Infect (2015) 0.84
Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. Influenza Other Respir Viruses (2014) 0.82
Vaccines for the prevention against the threat of MERS-CoV. Expert Rev Vaccines (2016) 0.81
A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus. Emerg Microbes Infect (2015) 0.81
Stability of Middle East respiratory syndrome coronavirus in milk. Emerg Infect Dis (2014) 0.81
Unanswered questions about the Middle East respiratory syndrome coronavirus (MERS-CoV). BMC Res Notes (2014) 0.80
Pathosphere.org: pathogen detection and characterization through a web-based, open source informatics platform. BMC Bioinformatics (2015) 0.80
Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol (2016) 0.80
Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Transbound Emerg Dis (2015) 0.80
Middle East respiratory syndrome: obstacles and prospects for vaccine development. Expert Rev Vaccines (2015) 0.80
Link of a ubiquitous human coronavirus to dromedary camels. Proc Natl Acad Sci U S A (2016) 0.79
Early detection of emerging zoonotic diseases with animal morbidity and mortality monitoring. Ecohealth (2014) 0.79
Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus. MBio (2017) 0.79
Inoculation of Goats, Sheep, and Horses with MERS-CoV Does Not Result in Productive Viral Shedding. Viruses (2016) 0.78
Unraveling the mysteries of Middle East respiratory syndrome coronavirus. Emerg Infect Dis (2014) 0.78
Anti-infective immunoadhesins from plants. Plant Biotechnol J (2015) 0.78
Risks of Death and Severe Disease in Patients With Middle East Respiratory Syndrome Coronavirus, 2012-2015. Am J Epidemiol (2016) 0.77
Investigating a mystery disease: tales from a viral detective. J Virol (2014) 0.77
A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the Hajj. Risk Anal (2014) 0.77
Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction. Pathog Glob Health (2015) 0.76
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection. Sci Rep (2016) 0.76
Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob Agents Chemother (2014) 0.76
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus. Virology (2015) 0.76
Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design. Sci Rep (2016) 0.76
Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study. BMC Infect Dis (2017) 0.75
Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein. Sci Rep (2017) 0.75
Middle East Respiratory Syndrome-Coronavirus Infection: A Case Report of Serial Computed Tomographic Findings in a Young Male Patient. Korean J Radiol (2016) 0.75
Isolation and Characterization of Dromedary Camel Coronavirus UAE-HKU23 from Dromedaries of the Middle East: Minimal Serological Cross-Reactivity between MERS Coronavirus and Dromedary Camel Coronavirus UAE-HKU23. Int J Mol Sci (2016) 0.75
Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus. PLoS One (2017) 0.75
Patterns of Human Respiratory Viruses and Lack of MERS-Coronavirus in Patients with Acute Upper Respiratory Tract Infections in Southwestern Province of Saudi Arabia. Adv Virol (2017) 0.75
One-Pot Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) for Detecting MERS-CoV. Front Microbiol (2017) 0.75
Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect (2017) 0.75
Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016. Euro Surveill (2017) 0.75
MERS-coronavirus: From discovery to intervention. One Health (2016) 0.75
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol (2017) 0.75
The history and epidemiology of Middle East respiratory syndrome corona virus. Multidiscip Respir Med (2017) 0.75
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 22.75
Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill (2012) 7.96
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis (2013) 7.83
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis (2013) 6.08
Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis (2013) 5.25
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill (2012) 4.95
Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis (2013) 4.78
Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med (2013) 4.66
Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill (2013) 4.37
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet (2013) 3.40
Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill (2013) 2.99
Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill (2013) 2.97
Antibody-profiling technologies for studying humoral responses to infectious agents. Expert Rev Vaccines (2010) 1.67
Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J Infect Dis (2013) 1.23
Missing information in animal surveillance of MERS-CoV. Lancet Infect Dis (2014) 1.06
Global trends in emerging infectious diseases. Nature (2008) 23.66
Global patterns of influenza a virus in wild birds. Science (2006) 13.80
Airborne transmission of influenza A/H5N1 virus between ferrets. Science (2012) 13.48
Bats are natural reservoirs of SARS-like coronaviruses. Science (2005) 13.44
A metagenomic survey of microbes in honey bee colony collapse disorder. Science (2007) 11.72
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (2009) 7.80
A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med (2011) 7.29
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77
Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature (2010) 6.55
H5N1 Virus Attachment to Lower Respiratory Tract. Science (2006) 6.34
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog (2008) 6.07
Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci U S A (2006) 5.65
A horizon scan of global conservation issues for 2010. Trends Ecol Evol (2009) 5.61
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43
New DNA viruses identified in patients with acute viral infection syndrome. J Virol (2005) 5.26
Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog (2009) 4.88
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol (2007) 4.86
Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis (2013) 4.78
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol (2003) 4.67
H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet (2007) 4.62
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet (2010) 4.52
West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol (2006) 4.46
Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev (2008) 4.46
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis. J Virol (2009) 4.14
MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J Infect Dis (2006) 4.12
Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA (2013) 4.08
Emerging infectious diseases of plants: pathogen pollution, climate change and agrotechnology drivers. Trends Ecol Evol (2004) 3.90
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Effective post-exposure treatment of Ebola infection. PLoS Pathog (2007) 3.69
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet (2003) 3.57
Rapid identification of known and new RNA viruses from animal tissues. PLoS Pathog (2008) 3.54
Host heterogeneity dominates West Nile virus transmission. Proc Biol Sci (2006) 3.54
Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51
Biodiversity. Confronting amphibian declines and extinctions. Science (2006) 3.51
Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence. Environ Health Perspect (2004) 3.47
Prediction and prevention of the next pandemic zoonosis. Lancet (2012) 3.44
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis (2003) 3.33
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature (2013) 3.27
A recently identified rhinovirus genotype is associated with severe respiratory-tract infection in children in Germany. J Infect Dis (2007) 3.19
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (2006) 3.15
Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg Infect Dis (2005) 3.02
Discovery of an ebolavirus-like filovirus in europe. PLoS Pathog (2011) 2.99
Bushmeat hunting, deforestation, and prediction of zoonoses emergence. Emerg Infect Dis (2005) 2.93
Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg (2010) 2.92
West Nile virus risk assessment and the bridge vector paradigm. Emerg Infect Dis (2005) 2.88
Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med (2012) 2.87
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A (2003) 2.82
Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis (2010) 2.81
Surveillance of influenza A virus in migratory waterfowl in northern Europe. Emerg Infect Dis (2007) 2.76
Pandemic human viruses cause decline of endangered great apes. Curr Biol (2008) 2.73
Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med (2015) 2.71
Development of a new vaccine for the prevention of Lassa fever. PLoS Med (2005) 2.71
Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells (2004) 2.70
Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J Virol (2009) 2.70
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A (2010) 2.69
Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis (2010) 2.69
Effects of influenza A virus infection on migrating mallard ducks. Proc Biol Sci (2009) 2.69
Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol (2003) 2.66
A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis (2008) 2.65
Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One (2009) 2.65
The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis (2007) 2.58
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates. J Virol (2008) 2.58
Reproduction and nutritional stress are risk factors for Hendra virus infection in little red flying foxes (Pteropus scapulatus). Proc Biol Sci (2008) 2.55
The ecology and impact of chytridiomycosis: an emerging disease of amphibians. Trends Ecol Evol (2009) 2.50
A strategy to estimate unknown viral diversity in mammals. MBio (2013) 2.48
Pneumonia from human coronavirus in a macaque model. N Engl J Med (2013) 2.47
Possible sexual transmission of Ebola virus - Liberia, 2015. MMWR Morb Mortal Wkly Rep (2015) 2.45